BIORBYT LTD. Non-Antibody Products — page 2 of 5
Non-Antibody Products
Page 2,654 of 5,306
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| LCE2D | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb599593 | More Info |
| LCE2D Human Over-expression Lysate | LCE2D HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1374754 | More Info |
| LCE2D Human Over-expression Lysate | Transient overexpression lysate of late cornified envelope 2D (LCE2D) | 100 ug | orb1354418 | More Info |
| LCE3D Human Over-expression Lysate | LCE3D HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1372064 | More Info |
| LCE3D Human Over-expression Lysate | Transient overexpression lysate of late cornified envelope 3D (LCE3D) | 100 ug | orb1351728 | More Info |
| LCE1D siRNA (Human) | siRNA to inhibit LCE1D expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1850696 | More Info |
| LCE2D siRNA (Human) | siRNA to inhibit LCE2D expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1850691 | More Info |
| LCE3D siRNA (Human) | siRNA to inhibit LCE3D expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1854704 | More Info |
| LCE3E | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb599641 | More Info |
| LCE3E Human Over-expression Lysate | LCE3E HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1374749 | More Info |
| LCE3E Human Over-expression Lysate | Transient overexpression lysate of late cornified envelope 3E (LCE3E) | 100 ug | orb1354413 | More Info |
| LCE1E siRNA (Human) | siRNA to inhibit LCE1E expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1850695 | More Info |
| LCE3E siRNA (Human) | siRNA to inhibit LCE3E expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1850687 | More Info |
| LCE1F siRNA (Human) | siRNA to inhibit LCE1F expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1850694 | More Info |
| L929 Cell Line Lysate (Mouse subcutaneous connective tissue) | Avoid the trouble of preparing cell line protein extract in your laborator… | 100 ug | orb1765667 | More Info |
| L929 Cell Line (Mouse subcutaneous connective tissue) | This is a subclone of `L' cells originally established by W R Earle in 194… | vial | orb1765535 | More Info |
| L929 Cell Line RNA (Mouse subcutaneous connective tissue) | L929 Cell Line RNA (Mouse subcutaneous connective tissue) | 100 ug | orb1765440 | More Info |
| LCH 7749944 | LCH 7749944 (GNF-PF-2356) is a novel and potent PAK4 with IC50 of 14.93 uM… | 1 g, 100 mg, 250 mg | orb746450 | More Info |
| LCH-7749944 | LCH-7749944 effectively suppresses the proliferation of human gastric canc… | 25 mg, 5 mg | orb1219723 | More Info |
| LCH-7749944 | Purity 99.28%. MW: 350.41 | 10 mg, 5 mg, 25 mg, 100 mg, 50 mg, 1 mg | orb1309493 | More Info |
| L-Chicoric Acid | Purity 99.00%. MW: 474.37 | 1 mg, 10 mg, 100 mg, 50 mg, 25 mg, 5 mg | orb1300155 | More Info |
| L-Chlorozotocin | Purity 98.00%. MW: 313.69 | 5 mg, 50 mg, 100 mg | orb1703150 | More Info |
| LCHN siRNA (Human) | siRNA to inhibit LCHN expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1856871 | More Info |
| LCHN siRNA (Mouse) | siRNA to inhibit LCHN expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1835609 | More Info |
| LCHN siRNA (Rat) | siRNA to inhibit LCHN expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1828544 | More Info |
| LCI-699 | n/a | 2 mg, 5 mg | orb1895972 | More Info |
| L-Citruline | Purity ≥98%. MW: 175.18 | 1 g, 20 mg | orb507865 | More Info |
| L(+)-Citrulline | Purity > 98%,Standard References. MW: 175.19 | 20 mg | orb104909 | More Info |
| L-Citrulline | L-Citrulline is an amino acid derived from ornithine in the catabolism of… | 100 mg, 50 mg | orb1221478 | More Info |
| L-Citrulline | Purity ≥98%. MW: 175.19 | 100 g, 25 g, 5 g, 1 g | orb321868 | More Info |
| L-Citrulline | Purity 99.61%. MW: 175.19 | 50 mg, 100 mg, 1 g, 500 mg | orb1302545 | More Info |
| L-Citrulline | n/a | 500 mg | orb1889679 | More Info |
| L-Citrulline BSA Conjugate | L-Citrulline conjugated to Bovine Serum Albumin (BSA). Purity > 98% | 50 ug | orb1822393 | More Info |
| L-Citrulline BSA Conjugate | L-Citrulline conjugated to Bovine Serum Albumin (BSA). Purity > 98%. | 4 x 50 ug | orb1714271 | More Info |
| L-Citrulline BSA Conjugate | L-Citrulline conjugated to Bovine Serum Albumin (BSA). Purity > 98%. | 2 x 50 ug | orb1714272 | More Info |
| LCK | n/a | 10 ug | orb528557 | More Info |
| LC-Kemptide Biotin peptide | LC-Kemptide Biotin peptide. Purity > 95%. | 5 mg | orb71436 | More Info |
| LCK Human Over-expression Lysate | LCK HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1364383 | More Info |
| LCK Human Over-expression Lysate | Transient overexpression lysate of lymphocyte-specific Protein tyrosine ki… | 100 ug | orb1344042 | More Info |
| LCK Human Over-expression Lysate | Transient overexpression lysate of lymphocyte-specific Protein tyrosine ki… | 100 ug | orb1357585 | More Info |
| LCK Immunizing peptide | n/a | 100 ug | orb66355 | More Info |
| Lck-IN-1 | Purity 98.00%. MW: 253.3 | 5 mg, 50 mg, 100 mg | orb1685346 | More Info |
| Lck-IN-1 | Lck-IN-1 is a potent lymphocyte protein tyrosine kinase (Lck) inhibitor ex… | 1 g | orb1909975 | More Info |
| LC kinetic stabilizer-1 | Purity 98.00%. MW: 473.57 | 100 mg, 50 mg, 5 mg | orb1744999 | More Info |
| LC kinetic stabilizer-2 | Purity 98.00%. MW: 457.56 | 100 mg, 50 mg, 5 mg | orb1744998 | More Info |
| Lck Inhibitor | Lck Inhibitor is a new class of compounds that are potent inhibitors of Lc… | 1 g, 100 mg, 250 mg | orb364017 | More Info |
| Lck Inhibitor | Purity 98.00%. MW: 530.62 | 50 mg, 100 mg, 5 mg | orb1707088 | More Info |
| Lck inhibitor 2 | A potent tyrosine kinases inhibitor with IC50 of 13 / 9/3 / 26/2 nM for Lc… | 10 mg, 100 mg, 50 mg | orb611762 | More Info |
| Lck inhibitor 2 | Purity 98.00%. MW: 335.36 | 100 mg, 50 mg, 5 mg | orb1707089 | More Info |
| Lck inhibitor 2 | n/a | 5 mg, 10 mg, 50 mg | orb1893579 | More Info |
| Lck inhibitor II | Purity 98.00%. MW: 446.511 | 50 mg, 100 mg, 5 mg | orb1741131 | More Info |
| Lck Inhibitor III | Purity 98.00%. MW: 478.54 | 100 mg, 50 mg, 5 mg | orb1744809 | More Info |
| LCKLSL acetate | Purity 99.90%. MW: 735.93 | 100 mg, 25 mg, 200 mg, 1 mg, 5 mg, 10 mg, 50 mg | orb1679080 | More Info |
| LCK peptide | The peptide is used to block anti-LCK antibody reactivity. Purity > 85%. | 5 mg, 1 mg | orb217537 | More Info |
| LCK peptide | The peptide is used to block anti-LCK. Purity > 85%. | 5 mg, 1 mg | orb217536 | More Info |
| LCK peptide | The peptide is used to LCK antibody reactivity. Purity > 85%. | 5 mg, 1 mg | orb339306 | More Info |
| LCK Peptide | n/a | 0.1 mg | orb1235471 | More Info |
| LCK (Phospho-Y505) peptide | The peptide is used to LCK (pY505) antibody. Purity > 85%. | 5 mg, 1 mg | orb315854 | More Info |
| LCK siRNA (Human) | siRNA to inhibit LCK expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1865594 | More Info |
| LCK siRNA (Mouse) | siRNA to inhibit LCK expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1846970 | More Info |
| LCK siRNA (Rat) | siRNA to inhibit LCK expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1828507 | More Info |
| LCL161 | LCL161, a SMAC mimetic, potently binds to and inhibits multiple IAPs (i.e.… | 100 mg, 200 mg, 50 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1227172 | More Info |
| LCL161 | Purity 99.72%. MW: 500.63 | 100 mg, 50 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1306530 | More Info |
| LCL-161 | LCL161 is an oral small molecule antagonist of Apoptosis Proteins (IAPs) t… | 100 mg, 1000 mg, 250 mg, 10 mM * 1 mL in DMSO | orb181046 | More Info |
| LCL-161 | Purity ≥99%, ≥99%ee, de. MW: 500.63 | 25 mg, 5 mg, 1 mg | orb322832 | More Info |
| LCL-161 | n/a | 5 mg, 10 mg, 10 mm, 25 mg | orb1900169 | More Info |
| LCL521 | LCL521 is an acid ceramidase (ACDase) inhibitor. LCL521 also inhibits the… | 1 g, 100 mg, 250 mg | orb573263 | More Info |
| LCL521 | Purity 98.00%. MW: 592.77 | 100 mg, 50 mg, 5 mg | orb1709269 | More Info |
| LCL521 | n/a | 5 mg, 10 mg, 50 mg, 100 mg | orb1887388 | More Info |
| LCLAT1 Human Over-expression Lysate | LCLAT1 HEK293T cell transient overexpression lysate (as WB positive contro… | 20 ug | orb1375069 | More Info |
| LCLAT1 Human Over-expression Lysate | Transient overexpression lysate of lysocardiolipin acyltransferase 1 (LCLA… | 100 ug | orb1354733 | More Info |
| LCLAT1 siRNA (Human) | siRNA to inhibit LCLAT1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1851616 | More Info |
| LCLAT1 siRNA (Mouse) | siRNA to inhibit LCLAT1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1836882 | More Info |
| L-Clausenamide | Purity 98.00%. MW: 297.35 | 50 mg, 100 mg, 5 mg | orb1696579 | More Info |
| LCL521 dihydrochloride | Purity > 98%. MW: 665.69 | 100 mg, 50 mg, 10 mg, 5 mg | orb1179551 | More Info |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Return to Profile